Haleon, the maker of Sensodyne, saw its stock decline as investor concerns over sales growth overshadowed a reported profit beat.

Haleon has signed a five-year agreement with Microsoft to deploy agentic AI across its global operations. This partnership aims to integrate advanced artificial intelligence into Haleon's worldwide business processes.

The growth prospects for Haleon plc (HLN) stock are being re-evaluated following a recent downgrade by financial analysts.

Haleon, a leading global consumer health company, participated as a Platinum Sponsor in the Dental Run 2026, held on Sunday, May 17, 2026, at Gouda Park in Greece, actively supporting public awareness for healthy smiles.

Haleon (HLN) has announced the appointment of Richard Manso as its new US Chief Marketing Officer, with a focus on enhancing consumer agility within the company.

British health products company Haleon fulfilled an advertising promise by sponsoring a Brazilian football club after its relegation to Série B.

Haleon, a consumer healthcare company, is looking to expand its growth by establishing a new operational unit in Shanghai, China.

Március 20-án tartjuk a Szájápolás Világnapját, ennek alkalmából a Haleon, mely a Sensodyne, a Parodontax és a Corega gyártója, informatív eseményt szervezett.

Haleon (HLN) achieved 3% organic growth in 2025, attributing the success to its 'Win as One' strategy.

Haleon's shares dropped by 3.4% as the company's revenue growth failed to meet its own medium-term targets.

Haleon plc announced Non-GAAP EPS of 10.30p and revenue of £5.6 billion, while also reaffirming its full-year outlook.

Haleon has secured a five-year deal with Microsoft, a development that is expected to have implications for Haleon's stock performance.

Haleon has initiated a voluntary nationwide recall for specific batches of its Gas-X Extra Strength Softgels, citing undisclosed reasons for the action.

An analysis provides insights into what lies ahead for Haleon PLC, offering a perspective on its future prospects and market standing.

Haleon, a consumer healthcare company, has stated its strong commitment and importance to the China market.

Haleon is focusing on expanding its growth by establishing a new operational unit in Shanghai, signaling strategic investment in the Chinese market.

Jefferies has reiterated its 'Buy' rating on Haleon plc (HLN), indicating continued confidence in the consumer healthcare company's stock performance.

Thousands of children from vulnerable communities will receive oral hygiene products through a partnership between Haleon Romania & Save the Children

Haleon presented highlights from its H2 earnings call, covering its financial performance for the latter half of the fiscal year.

Haleon has announced a partnership with Microsoft to advance its digital and artificial intelligence capabilities, aiming to innovate in the consumer health sector.

Haleon, a consumer health company, has signed a five-year partnership agreement with technology giant Microsoft.

Haleon has introduced a new corporate identity in Nigeria and announced a partnership with Fidson Healthcare, aiming to reinforce local production and support trusted health brands in the country.

An analyst has repeated a 'buy' rating for Haleon, suggesting the company's performance may be stronger than commonly perceived.

An investigation by AFP and The Gecko Project uncovered that plantation wood from Indonesia was used in 'climate-neutral' packaging, prompting British pharmaceutical company Haleon to terminate its partnership with the packaging manufacturer.

Η Haleon, με αφορμή την Παγκόσμια Ημέρα Στοματικής Υγείας (20 Μαρτίου), ανακοινώνει τη συνεργασία της με τους Γιατρούς του Κόσμου για την υποστήριξη του Κοινωνικού Οδοντιατρείου στην Αθήνα.

Cu ocazia Zilei Mondiale a Sănătății Orale, celebrată în fiecare an în data de 20 Martie, Haleon România – producătorul brandurilor Sensodyne și pardontax, lider global în sănătatea consumatorului și…

The CEO of Haleon aims to drive growth in China and India through the establishment of a new manufacturing plant and an aggressive mergers and acquisitions strategy.

Haleon (HLN) experienced a 7.7% drop in its stock price after reporting a miss on its revenue targets.

Haleon, the company behind Sensodyne, has projected below-target growth for 2026, attributing the outlook to weak demand in the United States.